ATE390428T1 - Neue oripavinderivate und deren verwendungen als arzneimittel - Google Patents
Neue oripavinderivate und deren verwendungen als arzneimittelInfo
- Publication number
- ATE390428T1 ATE390428T1 AT02764501T AT02764501T ATE390428T1 AT E390428 T1 ATE390428 T1 AT E390428T1 AT 02764501 T AT02764501 T AT 02764501T AT 02764501 T AT02764501 T AT 02764501T AT E390428 T1 ATE390428 T1 AT E390428T1
- Authority
- AT
- Austria
- Prior art keywords
- methyl
- new
- medicinal products
- oripavine derivatives
- cycloalkyl
- Prior art date
Links
- ZKLXUUYLEHCAMF-UUWFMWQGSA-N Oripavine Chemical class C([C@@H](N(CC1)C)C2=CC=C3OC)C4=CC=C(O)C5=C4[C@@]21[C@H]3O5 ZKLXUUYLEHCAMF-UUWFMWQGSA-N 0.000 title abstract 2
- 229940051808 oripavine derivative analgesics Drugs 0.000 title abstract 2
- 229940126601 medicinal product Drugs 0.000 title 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 2
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 abstract 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
- 239000008896 Opium Substances 0.000 abstract 1
- 229940035676 analgesics Drugs 0.000 abstract 1
- 239000000730 antalgic agent Substances 0.000 abstract 1
- 125000004432 carbon atom Chemical group C* 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 1
- 125000004981 cycloalkylmethyl group Chemical group 0.000 abstract 1
- 125000004850 cyclobutylmethyl group Chemical group C1(CCC1)C* 0.000 abstract 1
- 125000004186 cyclopropylmethyl group Chemical group [H]C([H])(*)C1([H])C([H])([H])C1([H])[H] 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- 231100000252 nontoxic Toxicity 0.000 abstract 1
- 230000003000 nontoxic effect Effects 0.000 abstract 1
- 229960001027 opium Drugs 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D489/00—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
- C07D489/09—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: containing 4aH-8, 9 c-Iminoethano- phenanthro [4, 5-b, c, d] furan ring systems condensed with carbocyclic rings or ring systems
- C07D489/10—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: containing 4aH-8, 9 c-Iminoethano- phenanthro [4, 5-b, c, d] furan ring systems condensed with carbocyclic rings or ring systems with a bridge between positions 6 and 14
- C07D489/12—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: containing 4aH-8, 9 c-Iminoethano- phenanthro [4, 5-b, c, d] furan ring systems condensed with carbocyclic rings or ring systems with a bridge between positions 6 and 14 the bridge containing only two carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Addiction (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB011421495A CN1233645C (zh) | 2001-09-14 | 2001-09-14 | 新的东罂粟碱衍生物及其医药用途 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE390428T1 true ATE390428T1 (de) | 2008-04-15 |
Family
ID=4676657
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT02764501T ATE390428T1 (de) | 2001-09-14 | 2002-09-13 | Neue oripavinderivate und deren verwendungen als arzneimittel |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP1439179B1 (enExample) |
| JP (1) | JP4532109B2 (enExample) |
| CN (1) | CN1233645C (enExample) |
| AT (1) | ATE390428T1 (enExample) |
| DE (1) | DE60225827D1 (enExample) |
| MX (1) | MXPA04002422A (enExample) |
| WO (1) | WO2003024972A1 (enExample) |
| ZA (1) | ZA200402733B (enExample) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1939920B (zh) * | 2005-09-29 | 2011-08-31 | 中国人民解放军军事医学科学院毒物药物研究所 | 东罂粟碱类化合物及其医药用途 |
| US8993764B2 (en) | 2006-01-05 | 2015-03-31 | Mallinckrodt Llc | Use of oripavine as a starting material for buprenorphine |
| US20080125592A1 (en) | 2006-10-17 | 2008-05-29 | Penick Corporation | Process for preparing oxymorphone, naltrexone, and buprenorphine |
| CA2674915C (en) | 2006-10-17 | 2015-06-30 | Penick Corporation | Process for preparing oxymorphone |
| WO2009122436A2 (en) * | 2008-03-31 | 2009-10-08 | Sun Pharmaceutical Industries Ltd. | An improved process for the preparation of morphinane analogues |
| US8269006B2 (en) | 2008-09-30 | 2012-09-18 | Mallinckrodt Llc | Processes for the selective amination of ketomorphinans |
| PL2342207T3 (pl) | 2008-09-30 | 2016-05-31 | SpecGx LLC | Sposoby alkilowania norbuprenorfiny ze zmniejszonym powstawaniem zanieczyszczeń |
| US8232396B2 (en) | 2008-09-30 | 2012-07-31 | Mallinckrodt Llc | Processes for the synthesis of opiates alkaloids with reduced impurity formation |
| WO2010039210A1 (en) | 2008-09-30 | 2010-04-08 | Mallinckrodt Inc. | Processes for the hydrogenation of opiate alkaloid derivatives |
| US8232397B2 (en) | 2008-09-30 | 2012-07-31 | Mallinckrodt Llc | Processes for the production of buprenorphine with reduced impurity formation |
| US8232398B2 (en) | 2008-09-30 | 2012-07-31 | Mallinckrodt Llc | Recycling process for increasing the yield of opiate alkaloid derivatives |
| TWI541246B (zh) * | 2008-12-08 | 2016-07-11 | 歐陸斯迪公司 | 二氫羥戊甲嗎啡 |
| CN102462680B (zh) * | 2010-11-04 | 2016-08-03 | 中国人民解放军军事医学科学院毒物药物研究所 | 噻吩诺啡的长效缓释微球及其组合物和制备方法 |
| CN102382118A (zh) * | 2011-05-23 | 2012-03-21 | 浙江仙琚制药股份有限公司 | 一种7ɑ-乙酰基-6,14-乙基桥四氢蒂巴因的制备方法 |
| GB201309654D0 (en) | 2013-05-30 | 2013-07-17 | Euro Celtique Sa | Method |
| EP3023427A1 (en) | 2014-11-19 | 2016-05-25 | Siegfried AG | Improved method of manufacturing buprenorphine and analogues thereof from oripavine |
| EP3067357A1 (en) | 2015-03-11 | 2016-09-14 | Siegfried AG | Method of manufacturing stereoisomers of buprenorphine and analogues thereof |
| GB2550566A (en) | 2016-05-19 | 2017-11-29 | Chapelglade Ltd | Mattress evaluation system and method |
| CN108530452B (zh) * | 2017-03-01 | 2023-02-03 | 泰州华元医药科技有限公司 | 高效抗成瘾药物 |
| EP4613751A1 (en) | 2024-03-07 | 2025-09-10 | Siegfried AG | Method of making chemical compounds useful for the synthesis of buprenorphine |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB925723A (en) * | 1960-09-05 | 1963-05-08 | J F Macfarlan & Company Ltd | Novel thebaine derivatives |
| US3474101A (en) * | 1960-09-05 | 1969-10-21 | Reckitt & Sons Ltd | Thebaine and oripavine derivatives |
| DE2230154A1 (de) * | 1972-06-21 | 1974-01-17 | Boehringer Sohn Ingelheim | N-(heteroaryl-methyl)-6,14-endoaetheno7alpha-hydroxyalkyl-tetrahydro-nororipavine und -thebaine, deren hydrierungsprodukte und saeureadditionssalze sowie verfahren zu deren herstellung |
| KR100204659B1 (ko) * | 1996-05-28 | 1999-06-15 | 강재헌 | 신규한 부프레노핀계 진통제용 화합물 |
-
2001
- 2001-09-14 CN CNB011421495A patent/CN1233645C/zh not_active Expired - Lifetime
-
2002
- 2002-09-13 AT AT02764501T patent/ATE390428T1/de not_active IP Right Cessation
- 2002-09-13 DE DE60225827T patent/DE60225827D1/de not_active Expired - Lifetime
- 2002-09-13 EP EP02764501A patent/EP1439179B1/en not_active Expired - Lifetime
- 2002-09-13 MX MXPA04002422A patent/MXPA04002422A/es active IP Right Grant
- 2002-09-13 WO PCT/CN2002/000642 patent/WO2003024972A1/zh not_active Ceased
- 2002-09-13 JP JP2003528819A patent/JP4532109B2/ja not_active Expired - Lifetime
-
2004
- 2004-04-07 ZA ZA2004/02733A patent/ZA200402733B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ZA200402733B (en) | 2005-02-23 |
| EP1439179B1 (en) | 2008-03-26 |
| CN1233645C (zh) | 2005-12-28 |
| JP4532109B2 (ja) | 2010-08-25 |
| WO2003024972A1 (en) | 2003-03-27 |
| DE60225827D1 (de) | 2008-05-08 |
| CN1408714A (zh) | 2003-04-09 |
| EP1439179A4 (en) | 2005-10-12 |
| WO2003024972A8 (en) | 2004-06-17 |
| MXPA04002422A (es) | 2005-04-11 |
| JP2005506985A (ja) | 2005-03-10 |
| EP1439179A1 (en) | 2004-07-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60225827D1 (de) | Neue oripavinderivate und deren verwendungen als arzneimittel | |
| AU2134402A (en) | Antiviral agents | |
| SE9904508D0 (sv) | New compounds | |
| ATE233761T1 (de) | Neue chinuclidin-derivate und diese enthaltende pharmazeutische präparate | |
| NZ231062A (en) | ((1,2 benzisoxazol-3-yl)piperidinyl alkyl)-6,7,8,9-tetrahydro-4h-pyrido(1,2-a)pyrimdin-4-one derivatives and antipsychotic compositions | |
| DE60000120D1 (de) | Bicyclische Carbonyl-Indolverbindungen als entzündungshemmende/ analgetische Wirkstoffe und als COX-2 Inhibitoren | |
| DE69230163D1 (de) | Thiazolylbenzofuranderivate, Verfahren zu deren Herstellung und pharmazeutische Zusammensetzungen, die sie enthalten | |
| HUP9801883A2 (hu) | Farnezil-protein transzferáz enzim gátló piperazinszármazékok, előállításuk, alkalmazásuk, és a vegyületeket tartalmazó gyógyszerkészítmények | |
| GB9902455D0 (en) | Chemical compounds | |
| ATE109149T1 (de) | 3-pyrrolidinylthio-1-azabicyclo(3.2.0>-hept-2-e - 2-carbonsäureverbindungen. | |
| DE60212110D1 (de) | Triazaspiro (5.5) undecanderivate und arzneimittel, die diese derivate als wirkstoff enthalten | |
| GR3020050T3 (en) | Leukotriene B4 antagonist | |
| PL359415A1 (en) | Oxadiazole derivatives having anticancer effects | |
| GR3005990T3 (enExample) | ||
| EP1084711A4 (en) | REMEDIES, CONTAINING PGD 2 ANTAGONISTS | |
| CA2465871A1 (en) | Heteroaryl derivatives as superior ligands for nociceptin receptor orl-1 | |
| IL99305A (en) | 4-substituted dihydropyrido [4,3-d]pyrimidines their preparation and analgesic and topical antiinflammatory compositions containing them for the treatment of skin disorders | |
| AU3231901A (en) | Phenoxyalkylamine derivatives useful as opioid delta receptor agonists | |
| HUT49879A (en) | Process for producing new 1',2'-dihydrospiro square brackets open imidazolidine-4,4'(3'h)-quinoline square brackets closed derivatives and pharmaceutical compositions comprising these compounds as active ingredient | |
| BR9909326A (pt) | Derivados de piridina inibidores de pde iv | |
| ATE170851T1 (de) | Guanidinothiazolederivate und ihre anwendung als h2-rezeptor-antagonisten | |
| HUP9901910A2 (hu) | Orfanin FQ(OFQ) receptor agonista és/vagy antagonista di- vagy tri-aza-spiro[4,5]dekán-származékok, előállításuk és alkalmazásuk | |
| ES2100768T3 (es) | Agente activo sobre el sistema nervioso central, procedimiento para su preparacion y composiciones farmaceuticas que lo contienen. | |
| IL143873A0 (en) | Dry skin remedies | |
| NZ330832A (en) | 5-heterocyclyl-alkyl-3-oxo-N-(heteroaryl or aryl)-pyrido[1,2-a]benzimidazole-4-carboxamide derivatives and medicaments |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |